Zribi A, Al Riyami K, Al Zahibi HS, Burney IA. Managing the Adverse Events Associated with the Combination Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos Univ Med J [Internet]. 2023Sep.20 [cited 2024May20];1(1). Available from: https://journals.squ.edu.om/index.php/squmj/article/view/6005